Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Health & Medicine News -- ScienceDaily https://ift.tt/3hpjKKi

Comments

Popular posts from this blog